XLO

7.5600.67%
KM

Kevin M. Brennan

Senior Vice President of Finance & Accounting

Mr. Kevin M. Brennan is Senior Vice President of Finance and Accounting of Xilio Therapeutics, Inc. from April 2023. He joined the Xilio Therapeutics, Inc. in April 2023. He has finance and accounting experience within the biotechnology industry. Prior to joining the Xilio, Mr. Brennan most recently served as Vice President of Finance at Allena Pharmaceuticals, Inc. from November 2020 to March 2023, where he oversaw Allena's accounting and finance operations and strategy, as well as public company reporting. From October 2011 to October 2020, he held finance and accounting roles of increasing responsibility at Allena. Prior to that, he served in finance and accounting roles at various companies within the biotechnology industry. He began his career in the audit practice at KPMG LLP, and he received a B.S. in accounting from the Wallace Carroll School of Management at Boston College.

Positions